HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radiotherapy in benign orbital disease. II: Ophthalmic Graves' disease and orbital histiocytosis X.

Abstract
Ophthalmic Graves' disease and histiocytosis X involving the orbit are occasionally refractory to treatment, so that vision may be threatened. In these situations megavoltage external beam radiotherapy should be employed, and the indications for this treatment are discussed. A highly accurate technique is described, using precise planning with information obtained from high definition CT scans, a complete patient head shell for immobilisation, and modern megavoltage radiotherapy treatment machines. As a result the dose to the lens is minimised (to a maximum of 10% of the prescribed dose), and late morbidity will be small. Two cases are described to illustrate this procedure and the response to treatment.
AuthorsA N Harnett, D Doughty, A Hirst, P N Plowman
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 72 Issue 4 Pg. 289-92 (Apr 1988) ISSN: 0007-1161 [Print] England
PMID3259894 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Child, Preschool
  • Female
  • Graves Disease (diagnostic imaging, radiotherapy)
  • Histiocytosis, Langerhans-Cell (diagnostic imaging, radiotherapy)
  • Humans
  • Orbital Diseases (diagnostic imaging, radiotherapy)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: